Skip to main content

Trevi Therapeutics, Inc.

TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001563880

In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in Trevi Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+2 vs. Q2 2023
Shares held
48.7M
−139.4K (−0.3%) vs. Q2 2023
Total value
$106.1M
−$10.6M (−9.0%) vs. Q2 2023
New holders
6
13 more added
Sold out
4
17 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 55 institutions
Q1 2021: 19 institutionsQ2 2021: 17 institutionsQ3 2021: 18 institutionsQ4 2021: 17 institutionsQ1 2022: 23 institutionsQ2 2022: 32 institutionsQ3 2022: 40 institutionsQ4 2022: 37 institutionsQ1 2023: 36 institutionsQ2 2023: 53 institutionsQ3 2023: 55 institutionsQ4 2023: 63 institutionsQ1 2024: 80 institutionsQ2 2024: 77 institutionsQ3 2024: 93 institutionsQ4 2024: 110 institutionsQ1 2025: 137 institutionsQ2 2025: 154 institutionsQ3 2025: 164 institutionsQ4 2025: 184 institutionsQ1 2026: 198 institutionsQ2 2026: 218 institutions
Value heldQ3 2023: $106.1M
Q1 2021: $35.6MQ2 2021: $28.1MQ3 2021: $17.4MQ4 2021: $10.3MQ1 2022: $32.9MQ2 2022: $80.8MQ3 2022: $70.5MQ4 2022: $83.3MQ1 2023: $80.4MQ2 2023: $116.7MQ3 2023: $106.1MQ4 2023: $70.0MQ1 2024: $177.9MQ2 2024: $166.6MQ3 2024: $194.1MQ4 2024: $329.5MQ1 2025: $554.3MQ2 2025: $627.2MQ3 2025: $1.18BQ4 2025: $1.63BQ1 2026: $1.61BQ2 2026: $2.76B
Institutions holding TRVI and their total value by quarter
QuarterHoldersValue
Q2 2026218$2.76B
Q1 2026198$1.61B
Q4 2025184$1.63B
Q3 2025164$1.18B
Q2 2025154$627.2M
Q1 2025137$554.3M
Q4 2024110$329.5M
Q3 202493$194.1M
Q2 202477$166.6M
Q1 202480$177.9M
Q4 202363$70.0M
Q3 202355$106.1M
Q2 202353$116.7M
Q1 202336$80.4M
Q4 202237$83.3M
Q3 202240$70.5M
Q2 202232$80.8M
Q1 202223$32.9M
Q4 202117$10.3M
Q3 202118$17.4M
Q2 202117$28.1M
Q1 202119$35.6M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding TRVI in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
NEA Management Company, LLC11,370,376$24.8M1.91%00.0%Unchanged
Frazier Life Sciences Management, L.P.6,881,090$15.0M1.00%00.0%Unchanged
Rubric Capital Management LP5,684,420$12.4M0.52%00.0%Unchanged
Fairmount Funds Management LLC5,163,287$11.3M1.35%−27,073−0.5%Reduced
Viking Global Investors LPSuperinvestorViking Global Investors4,400,000$9.59M0.04%00.0%Unchanged
VR Adviser, LLC3,422,397$7.46M0.79%00.0%Unchanged
BlackRock Inc.2,148,263$4.68M0.00%−86,598−3.9%Reduced
Vanguard Group Inc1,957,875$4.27M0.00%+44,613+2.3%Added
Opaleye Management Inc.1,705,900$3.72M1.22%+4,400+0.3%Added
MAI Capital Management1,451,400$3.16M0.05%−83,252−5.4%Reduced
Silverarc Capital Management, LLC927,415$2.02M0.75%+41,491+4.7%Added
Geode Capital Management, LLC787,640$1.72M0.00%+8,819+1.1%Added
State Street Corp708,593$1.54M0.00%+28,000+4.1%Added
Northern Trust Corp315,556$687.9K0.00%−6,001−1.9%Reduced
Bridgeway Capital Management, LLC186,481$406.5K0.01%00.0%Unchanged
Tejara Capital Ltd180,227$392.9K0.22%00.0%Unchanged
J. Goldman & Co LP137,873$300.6K0.02%00.0%Unchanged
Bank of New York Mellon Corp134,080$292.3K0.00%+2,213+1.7%Added
Trust Co of Toledo NA117,145$255.4K0.05%−7,712−6.2%Reduced
Charles Schwab Investment Management Inc107,707$234.8K0.00%00.0%Unchanged
PFS Partners, LLC100,000$218.0K0.19%00.0%Unchanged
WealthTrust Axiom LLC93,500$203.8K0.07%00.0%Unchanged
Renaissance Technologies LLC67,300$147.0K0.00%−22,000−24.6%Reduced
Nuveen Asset Management, LLC66,935$145.9K0.00%00.0%Unchanged
Rhumbline Advisers54,272$118.3K0.00%+4,215+8.4%Added
Atom Investors LP38,520$84.0K0.02%+143+0.4%Added
New York State Common Retirement Fund36,785$80.2K0.00%+485+1.3%Added
Morgan Stanley34,714$75.7K0.00%−3,077−8.1%Reduced
Bank of America Corp28,693$62.5K0.00%−8,897−23.7%Reduced
United Bank28,450$62.0K0.01%00.0%Unchanged
Citadel Advisors LLC27,081$59.0K0.00%−33,372−55.2%Reduced
JPMorgan Chase & Co26,985$58.8K0.00%−6,189−18.7%Reduced
Goldman Sachs Group Inc26,150$57.0K0.00%−8,901−25.4%Reduced
Deutsche Bank AG25,070$54.7K0.00%+25,070New
Jane Street Group, LLC24,600$53.6K0.00%+24,600New
UBS Group AG22,575$49.2K0.00%−1,480−6.2%Reduced
American Century Companies Inc21,427$46.7K0.00%+21,427New
American International Group, Inc.20,775$45.3K0.00%+738+3.7%Added
SG Americas Securities, LLC19,597$43.0K0.00%+19,597New
Dimensional Fund Advisors LP18,382$40.1K0.00%+18,382New
Voya Investment Management LLC17,460$38.1K0.00%00.0%Unchanged
Invesco Ltd.16,046$35.0K0.00%00.0%Unchanged
Barclays PLC13,285$29.0K0.00%−767−5.5%Reduced
Wells Fargo & Company10,275$22.4K0.00%−5,562−35.1%Reduced
BNP Paribas Arbitrage, SA9,666$21.1K0.00%−1,183−10.9%Reduced
California State Teachers Retirement System9,185$20.0K0.00%−4,663−33.7%Reduced
STRS Ohio8,700$18.0K0.00%00.0%Unchanged
Royal Bank of Canada6,988$15.0K0.00%+2,645+60.9%Added
Tower Research Capital LLC (TRC)6,453$14.1K0.00%+4,951+329.6%Added
Amalgamated Bank4,049$9.00K0.00%00.0%Unchanged
Legal & General Group Plc3,974$8.66K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.3,438$7.50K0.00%00.0%Unchanged
NBC Securities, Inc.2,000$4.00K0.00%+2,000New
FMR LLC1,580$3.44K0.00%+694+78.3%Added
Citigroup Inc43$940.00%−12,355−99.7%Reduced
Innovis Asset Management LLC0$00.00%−43,232−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−11,571−100.0%Sold out
Zacks Investment Management0$00.00%−10,000−100.0%Sold out
LPL Financial LLC0$00.00%−10,000−100.0%Sold out